Anemia, Diamond-Blackfan - 25 Studies Found
| Terminated |
: Multi-Center Study of Iron Overload: Survey Study (MCSIO) :
|
| Terminated |
: Allo-HCT MUD for Non-malignant Red Blood Cell (RBC) Disorders: Sickle Cell, Thal, and DBA: Reduced Intensity Conditioning, Co-tx MSCs :
|
| Terminated |
: Multi-Center Study of Iron Overload: Pilot Study :
|
| Completed |
: Partially Matched Stem Cell Transplantation for Patients With Refractory Severe Aplastic Anemia or Refractory Cytopenias :
|
| Completed |
: Stem Cell Transplant for Bone Marrow Failure Syndromes :
|
| Completed |
: Expanded Access of Deferasirox to Patients With Congenital Disorders of Red Blood Cells and Chronic Iron Overload :
|
| Completed |
: Study of Deferasirox in Iron Overload From Beta-thalassemia Unable to be Treated With Deferoxamine or Chronic Anemias :
|
| Completed |
: Alemtuzumab, Fludarabine, and Busulfan Followed By Donor Stem Cell Transplant in Treating Young Patients With Hematologic Disorders :
|
| Active, not recruiting |
: Stem Cell Transplant for Hemoglobinopathy :
|
| Completed |
: Busulfan, Antithymocyte Globulin, and Fludarabine Followed By a Donor Stem Cell Transplant in Treating Young Patients With Blood Disorders, Bone Marrow Disorders, Chronic Myelogenous Leukemia in First Chronic Phase, or Acute Myeloid Leukemia in First Remission :
|